Upregulated FBXO32 promotes K48‐linked PHLPP2 polyubiquitination through K592 and K942 residues, inducing PHLPP2 degradation, activating PI3K–AKT signaling pathway, and consequently propelling malignant HCC progression. Here, FBXO32 is linked to hepatocellular carcinoma.